NCT01855360View on ClinicalTrials.gov

Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Amyloidosis; Heart (Manifestation)Senile Cardiac Amyloidosis
Interventions
DRUG

Tauroursodeoxycholic Acid and Doxycycline

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT01855360 - Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy | Biotech Hunter | Biotech Hunter